Imatinib can inhibit the receptor tyrosine kinase _____, making it useful for GI Stromal Tumors (GIST)
#2
Drug of choice for EGFR T790M mutation of Non-Small Cell Lung Cancer is
#3
Which kinase inhibitor has recently been approved for rx of breast cancer (Her2 +ve) with brain mets?_____
#4
Nivolumab is used as a checkpoint inhibitor in _____ lymphoma, advanced melanoma, advanced NSCLC that is previously treated, _____ carcinoma, and advanced head and neck cancers.
#5
Osimertinib, as a third-generation EGFR inhibitor is effective against NSCLC with _____ mutation
_____ and olaparib are PARP inhibitors approved for the treatment of advanced ovarian cancer.
#8
The two chimeric antitumor monoclonal antibodies are _____ and cetuximab
#9
Antineoplastic agents extracted from the Periwinkle plant is: _____
also called Catharanthus roseus
#10
Cetuximab is a monoclonal antibody against the _____ Receptor most commonly used to treat Stage IV colorectal cancer
Targeted Therapy Indian Medical PG Flashcards - Medical Study Cards
Master Targeted Therapy with OnCourse flashcards. These spaced repetition flashcards are designed for medical students preparing for NEET PG, USMLE Step 1, USMLE Step 2, MBBS exams, and other medical licensing examinations.
Targeted Therapy Flashcard Deck - 10 Cards
Flashcard 1: Imatinib can inhibit the receptor tyrosine kinase _____, making it useful for GI Stromal Tumors (GIST)
Answer: c-Kit
Flashcard 2: Drug of choice for EGFR T790M mutation of Non-Small Cell Lung Cancer is
Answer: Osimertinib
Flashcard 3: Which kinase inhibitor has recently been approved for rx of breast cancer (Her2 +ve) with brain mets?_____
Answer: Tucatinib
Flashcard 4: Nivolumab is used as a checkpoint inhibitor in _____ lymphoma, advanced melanoma, advanced NSCLC that is previously treated, _____ carcinoma, and advanced head and neck cancers.
Answer: Hodgkin's; renal cell
Flashcard 5: Osimertinib, as a third-generation EGFR inhibitor is effective against NSCLC with _____ mutation
